PERITONEAL CARCINOMA
Clinical trials for PERITONEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PERITONEAL CARCINOMA trials appear
Sign up with your email to follow new studies for PERITONEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo could slow ovarian Cancer's return
Disease control OngoingThis study tests whether adding the immunotherapy drug oregovomab to standard chemotherapy can help people with advanced ovarian cancer live longer without their cancer growing. About 615 newly diagnosed patients who had surgery to remove most of their cancer will receive either …
Matched conditions: PERITONEAL CARCINOMA
Phase: PHASE3 • Sponsor: CanariaBio Inc. • Aim: Disease control
Last updated May 17, 2026 01:59 UTC
-
New combo therapy shows promise in ovarian cancer battle
Disease control OngoingThis study tests whether adding the immunotherapy drug oregovomab to standard chemotherapy can help people with advanced ovarian, fallopian tube, or peritoneal cancer. About 88 newly diagnosed patients will receive either the drug combo or chemo alone before surgery. The main goa…
Matched conditions: PERITONEAL CARCINOMA
Phase: PHASE2 • Sponsor: CanariaBio Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Mushroom extract tested to ease chemo side effects in ovarian cancer
Symptom relief OngoingThis pilot study tests whether a supplement called AHCC, made from cultured mushroom mycelia, can improve quality of life for women with ovarian cancer who are receiving standard chemotherapy. About 20 participants will take either AHCC or a placebo during their treatment. The ma…
Matched conditions: PERITONEAL CARCINOMA
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Symptom relief
Last updated May 17, 2026 02:00 UTC